Pseudodisease, the next great epidemic in coronary atherosclerosis?

Archives of Internal Medicine

Volumn 171, Issue 14, 2011, Pages 1268-1269

  Lauer, Michael S ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

CANADA; CORONARY ARTERY ATHEROSCLEROSIS; EPIDEMIC; GERMANY; HUMAN; JAPAN; NOTE; PRIORITY JOURNAL; SCREENING TEST;

CANADA; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; GERMANY; HUMANS; INCIDENCE; JAPAN; MASS SCREENING; NEUROBLASTOMA; TOMOGRAPHY, X-RAY COMPUTED; TUMOR MARKERS, BIOLOGICAL; UNNECESSARY PROCEDURES;

EID: 79960954666     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2011.205     Document Type: Note

References (10)

1. Schilling FH, Spix C, Berthold F, et al. Neuroblastoma screening at one year of age. N Engl J Med. 2002;346(14):1047-1053. (Pubitemid 34984618)
2. Woods WG, Gao RN, Shuster JJ, et al. Screening of infants and mortality due to neuroblastoma. N Engl J Med. 2002;346(14):1041-1046. (Pubitemid 34984617)
3. Patz EF Jr, Goodman PC, Bepler GC. Screening for lung cancer. N Engl J Med. 2000;343(22):1627-1633. (Pubitemid 32162988)
4. Black WC,CzumJM. Screening coronaryCTangiography: no time soon.JAm Coll Radiol. 2007;4(5):295-299. (Pubitemid 46636412)
5. Lee TH, Brennan TA. Direct-to-consumermarketing of high-technology screening tests. N Engl J Med. 2002;346(7):529-531.
6. McEvoy JW, Blaha MJ, Nasir K, et al. Impact of coronary computed tomographic angiography results on patient and physician behavior in a low-risk population [published online May 23, 2011]. Arch Intern Med. 2011;171(14):1260-1268. doi:10.1001/archinternmed.2011.204.
7. Grimes DA, Schulz KF. Uses and abuses of screening tests. Lancet. 2002;359 (9309):881-884. (Pubitemid 34233764)
8. Greenland P, Alpert JS, Beller GA, et al American College of Cardiology Foundation; American Heart Association. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2010;56(25):e50-e103.
9. Mark DB, Berman DS, Budoff MJ, et al American College of Cardiology Foundation Task Force on Expert Consensus Documents. ACCF/ACR/AHA/ NASCI/SAIP/SCAI/SCCT 2010 expert consensus document on coronary computed tomographic angiography: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. Circulation. 2010;121(22):2509-2543.
10. Lord SJ, Irwig L, Simes RJ. When is measuring sensitivity and specificity sufficient to evaluate a diagnostic test, and when do we need randomized trials? Ann Intern Med. 2006;144(11):850-855. (Pubitemid 46780618)